Home  /   Products  /   Nervous system  /   D,L-hopantenic acid (Pantogam active) 300 mg – [60 capsules]

D,L-hopantenic acid (Pantogam active) 300 mg – [60 capsules]

$33.12

Nootropic drug with anticonvulsant action

SKU: 62392 Category:

Description

Pantogam Active Pharmacodynamics
The action of Pantogam active is due to the presence of gamma-aminobutyric acid (GABA) in its structure, which directly acts on the GABA receptor-channel complex. Pantogam active is a racemic mixture of equal amounts of the R form of hopantenic acid and its S isomer. The presence of the isomer improves transport and interaction of the drug with the GABA receptor. Pantogam active has a more pronounced nootropic and anticonvulsant effect than first-generation preparations of hypanthenic acid.
Pantogam active increases resistance of the brain to hypoxia and toxic substances, stimulates anabolic processes in neurons, combines a moderate sedative effect with a mild stimulating effect. It has anti-asthenic and mild anti-anxiety effects. Reduces motor excitability and regulates behavior. Activates mental activity and efficiency. Causes inhibition of pathologically increased bladder reflex and detrusor tone.

 

Indications
– Cognitive – disorders with organic lesions of the brain (including consequences of neuroinfections and craniocerebral injuries) and neurotic disorders;
– cerebrovascular insufficiency caused by atherosclerotic changes in brain vessels;
– extrapyramidal hyperkinesias (myoclonus-epilepsy, Huntington’s chorea, hepatolenticular degeneration, Parkinson’s disease, etc.), and also for treatment of extrapyramidal syndrome caused by taking neuroleptics;
– In epilepsy in conjunction with anticonvulsants;
– Psycho-emotional overload, decreased mental and physical performance, to improve concentration and memory;
– neurogenic urinary disorders (pollakiuria, imperative urges, imperative urinary incontinence, enuresis);
– schizophrenia in the treatment of complex disorders.

 

Contraindications .
Hypersensitivity, acute severe kidney diseases, patient’s age under 18 years (there are no clinical trials of earlier use).
Use during pregnancy and during breast-feeding:
The use of the drug is contraindicated in pregnancy and during breastfeeding.

 

Dosage and administration method.

 

  • Orally, 15-20 minutes after a meal, 1-3 capsules (0.3-0.9 g) 2-3 times a day, preferably in the morning and afternoon hours.
  • The maximum daily dose of 8 capsules (2.4 g).
  • Course of treatment – 1-4 months, sometimes up to 6-12 months.
  • After 3-6 months it is possible to conduct a second course of treatment.